Search Results - "Numerof, R P"
-
1
IL-2 stimulates the production of IL-1 alpha and IL-1 beta by human peripheral blood mononuclear cells
Published in The Journal of immunology (1950) (15-12-1988)“…Human PBMC were cultured in medium containing human rIL-2, and the supernatants and cell lysates were analyzed for IL-1 alpha and IL-1 beta using specific RIA…”
Get full text
Journal Article -
2
Regulation by CD45 of the tyrosine phosphorylation of high affinity IgE receptor beta- and gamma-chains
Published in The Journal of immunology (1950) (01-04-1995)“…Previous studies using tyrosine phosphatase inhibitors have implicated tyrosine phosphatases in the signal transduction pathway initiated by aggregation of Fc…”
Get full text
Journal Article -
3
Induction of circulating tumor necrosis factor (TNFα) as the mechanism for the febrile response to interleukin-2 (IL-2) in cancer patients
Published in Journal of clinical immunology (01-11-1988)“…Fever is frequently observed in cancer patients treated with high-dose recombinant human interleukin-2 (rIL-2). The preincubation of rIL-2 with polymyxin B, an…”
Get full text
Journal Article -
4
Inhibitors of tryptase for the treatment of mast cell-mediated diseases
Published in Current pharmaceutical design (01-10-1998)“…Human tryptase is a structurally unique and mast cell specific trypsin-like serine protease. Recent biological and immunological investigations have implicated…”
Get more information
Journal Article -
5
Pro-interleukin-1 beta production by a subpopulation of human T cells, but not NK cells, in response to interleukin-2
Published in Cellular immunology (01-10-1990)“…Previous studies have shown that IL-2-stimulated peripheral blood mononuclear cells (PBMC) produce IL-1 beta and TNF alpha and that monocytes are the primary…”
Get more information
Journal Article -
6
Expression and Characterization of Recombinant Mast Cell Tryptase
Published in Protein expression and purification (01-04-1999)“…Tryptase, a serine protease, is the major protein component in mast cells. In an animal model of asthma, tryptase has been established as an important mediator…”
Get full text
Journal Article -
7
Toxicity of immunotherapy with interleukin-2 and lymphokine-activated killer cells
Published in Pathology and immunopathology research (01-01-1988)“…Immunotherapy with IL-2 represents a major breakthrough in the management of renal cell carcinoma and malignant melanoma. At present, the toxicity of most IL-2…”
Get more information
Journal Article -
8
Induction of Foxp3 super(+) regulatory T cells with histone deacetylase inhibitors
Published in Cellular immunology (01-01-2009)“…Histone deacetylase inhibitors are under investigation in the clinic as a new class of anti-cancer therapeutics. While recent studies have also suggested their…”
Get full text
Journal Article -
9
Suppression of IL-2-induced SAA gene expression in mice by the administration of an IL-1 receptor antagonist
Published in Cytokine (Philadelphia, Pa.) (01-11-1992)“…The hepatic acute phase response induced by the administration of interleukin (IL)-2 is most likely mediated by secondary cytokines. In this investigation, we…”
Get more information
Journal Article -
10
Signal transduction through the conserved motifs of the high affinity IgE receptor FcεRI
Published in Seminars in immunology (01-02-1995)“…The high affinity receptor for IgE, FcεRI, possesses three ARAMs, one in the β chain (ARAM- β) and one in each member of the dimer of γ chains (ARAM- γ). These…”
Get full text
Journal Article -
11
Cytokines as potential therapeutic targets for inflammatory skin diseases
Published in European cytokine network (Montrouge) (01-06-2005)“…A network of pro-inflammatory cytokines is a central feature in the pathophysiology of cutaneous inflammatory diseases. Thus, the delineation of precise roles…”
Get more information
Journal Article